Related Experiment Video
Updated: Apr 14, 2026

08:16
Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
33.8K
When myopathy breaks the rules: a late-onset distal presentation.
Rachel Newby1, Stuart Jamieson1, Bjarne Udd2
1Department of Neurosciences, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
BMJ Case Reports
|April 26, 2015
Summary
This study details a rare distal myopathy caused by ZASP gene mutations, a newly identified form of myofibrillar myopathy. Early genetic testing is crucial for diagnosing this condition and assessing cardiac risks.
Area of Science:
- Neurology
- Genetics
- Pathology
Background:
- Myopathies often manifest as proximal or generalized muscle weakness.
- Recognizing diverse clinical presentations, including distal myopathies, is essential for accurate diagnosis.
- Myofibrillar myopathies (MFMs) are gaining attention due to recent genetic discoveries.
Observation:
- A case of distal myopathy with a purely distal lower limb phenotype is presented.
- The condition was genetically confirmed as ZASP (Z-band alternatively spliced PDZ motif-containing protein) myofibrillar myopathy (MFM).
Findings:
- ZASP MFM represents a newly characterized diagnosis within the spectrum of myofibrillar myopathies.
- The study elucidates the pathophysiology of ZASP and other MFMs.
- Differential diagnosis for late-onset distal symmetrical weakness is discussed, highlighting ZASP MFM's potential role.
Implications:
- ZASP MFM should be considered in the differential diagnosis of late-onset myopathies, particularly those with distal or autosomal dominant inheritance patterns.
- Cardiac evaluation is recommended for patients with ZASP MFM.
- The availability of genetic testing facilitates diagnosis and understanding of ZASP MFM.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
2.6K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.6K
Myasthenia Gravis: Diagnostic Tests
3.2K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.2K
Cross-bridge Cycle
125.5K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
125.5K
Disorders of the Skeletal Muscle
2.4K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.4K
Myasthenia Gravis: Overview and Treatment
3.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.6K
Muscle Recovery and Fatigue
5.1K
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
5.1K

